117 related articles for article (PubMed ID: 29578647)
1. Bioequivalence of Two Formulations of Gliclazide in a Randomized Crossover Study in Healthy Caucasian Subjects Under Fasting Conditions.
Pop DI; Oroian M; Bhardwaj S; Marcovici A; Khuroo A; Kochhar R; Vlase L
Clin Pharmacol Drug Dev; 2019 Jan; 8(1):16-21. PubMed ID: 29578647
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence evaluation of two brands of gliclazide 80 mg tablets (Glyzide & Diamicron)--in healthy human volunteers.
Najib N; Idkaidek N; Beshtawi M; Bader M; Admour I; Alam SM; Zaman Q; Dham R
Biopharm Drug Dispos; 2002 Jul; 23(5):197-202. PubMed ID: 12116051
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
Cho HY; Yoon H; Lim YC; Lee YB
Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
[TBL] [Abstract][Full Text] [Related]
4. A bioequivalence study of gliclazide based on quantification by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry.
Mendes GD; Moreira LD; Pereira Ados S; Borges A; Yui F; Mendes FD; de Nucci G
Int J Clin Pharmacol Ther; 2007 Mar; 45(3):175-85. PubMed ID: 17416113
[TBL] [Abstract][Full Text] [Related]
5. Single and multiple dose bioequivalence evaluation of two brands of gliclazide modified release tablets in healthy Chinese male volunteers.
Ling G; Sun J; Xu X; Sun Y; He Z
Arzneimittelforschung; 2006; 56(9):626-30. PubMed ID: 17063637
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence study of generic gliclazide and Diamicron formulations in healthy Thai male volunteers.
Rojanasthien N; Sugunta C; Rungapinan S; Kumsorn B; Sangdee C
Int J Clin Pharmacol Ther; 2003 Jul; 41(7):323-30. PubMed ID: 12875349
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic-pharmacodynamic equivalence of three gliclazide formulations in healthy human male subjects.
Samad A; Saha N; Monif T; Sharma PL; Pillai KK
Int J Clin Pharmacol Ther; 2011 Jul; 49(7):444-50. PubMed ID: 21726495
[TBL] [Abstract][Full Text] [Related]
8. Complete bioavailability and lack of food-effect on pharmacokinetics of gliclazide 30 mg modified release in healthy volunteers.
Delrat P; Paraire M; Jochemsen R
Biopharm Drug Dispos; 2002 May; 23(4):151-7. PubMed ID: 12015789
[TBL] [Abstract][Full Text] [Related]
9. Bioequivalence study of modified-release gliclazide tablets in healthy volunteers.
Rojanasthien N; Autsavakitipong T; Kumsorn B; Manorot M; Teekachunhatean S
ISRN Pharmacol; 2012; 2012():375134. PubMed ID: 23029622
[TBL] [Abstract][Full Text] [Related]
10. A single-dose, randomized, two-way crossover study comparing two olanzapine tablet products in healthy adult male volunteers under fasting conditions.
Elshafeey AH; Elsherbiny MA; Fathallah MM
Clin Ther; 2009 Mar; 31(3):600-8. PubMed ID: 19393850
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions.
Li W; Wang Y; Pei Y; Xia Y
Drug Des Devel Ther; 2021; 15():1091-1099. PubMed ID: 33727797
[TBL] [Abstract][Full Text] [Related]
12. Bioequivalence of a Generic Nateglinide Formulation in Healthy Chinese Volunteers under Fasting and Fed Conditions: A Randomized, Open-Label, Double-Cycle, Double-Crossover Study.
Yu M; Li X; Jin H; Chen L; Wang N; Wang H; Cao Y; Sui X; Gao X; Yang H; Wang W
Pharmacology; 2021; 106(7-8):418-425. PubMed ID: 33866315
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioequivalence of 0.5 mg lobeglitazone tablets in healthy male subjects
.
Lee SJ; Kim MG; Park SJ; Jeon JY
Int J Clin Pharmacol Ther; 2018 Sep; 56(9):426-433. PubMed ID: 29932413
[TBL] [Abstract][Full Text] [Related]
14. Comparative Bioavailability of Metformin Hydrochloride Oral Solution Versus Metformin Hydrochloride Tablets in Fasting Mexican Healthy Volunteers.
Garza-Ocañas L; González-Canudas J; Tamez-de la O E; Badillo-Castañeda C; Gómez-Meza MV; Romero-Antonio Y; Molina-Pérez A; Amador-Hernández AG
Adv Ther; 2019 Feb; 36(2):407-415. PubMed ID: 30565181
[TBL] [Abstract][Full Text] [Related]
15. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
Almeida S; Filipe A; Neves R; Pinho C; Pedroso P; Castillo A; Trabelsi F
Arzneimittelforschung; 2011; 61(1):32-9. PubMed ID: 21355444
[TBL] [Abstract][Full Text] [Related]
16. Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial.
Li Q; Hao Z; Yu Y; Tang Y
Biomed Pharmacother; 2021 Mar; 135():111221. PubMed ID: 33433351
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and bioequivalence study of an oral 8 mg dose of rosiglitazone tablets in Thai healthy volunteers.
Wittayalertpanya S; Chompootaweep S; Thaworn N; Khemsri W; Intanil N
J Med Assoc Thai; 2010 Jun; 93(6):722-8. PubMed ID: 20572378
[TBL] [Abstract][Full Text] [Related]
18. Quantification of gliclazide by semi-micro high-performance liquid chromatography: application to a bioequivalence study of two formulations in healthy subjects.
Park JY; Kim KA; Kim SL; Park PW
J Pharm Biomed Anal; 2004 Jun; 35(4):943-9. PubMed ID: 15193740
[TBL] [Abstract][Full Text] [Related]
19. Comparative fasting bioavailability of 2 bepotastine formulations in healthy male Chinese volunteers: an open-label, randomized, single-dose, 2-way crossover study.
Shentu J; Zhou H; Hu X; Wu G; Wu L; Zhu M; Zhai Y; Zheng Y; Liu J
Clin Ther; 2014 Apr; 36(4):579-85. PubMed ID: 24656153
[TBL] [Abstract][Full Text] [Related]
20. Bioequivalence and Pharmacokinetic Evaluation of Two Metformin Hydrochloride Tablets Under Fasting and Fed Conditions in Healthy Chinese Volunteers.
Huang XM; Wang GZ; He BB; Gao T; Long P; Zhang BK
Clin Pharmacol Drug Dev; 2020 Nov; 9(8):910-917. PubMed ID: 32936533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
